p-21 Activated Kinase as a Molecular Target for Chemoprevention in Diabetes.

Dammann, Kyle; Khare, Vineeta; Coleman, Clyde; Berdel, Henrik; Gasche, Christoph

Dammann, Kyle; Khare, Vineeta; Coleman, Clyde; Berdel, Henrik; Gasche, Christoph.

Afiliação

Dammann K; Department of Clinical Medicine, Medical University of the Americas, Devens, MA 01434, USA. dammannkw@gmail.com.
Khare V; Department of Internal Medicine III, Medical University of Vienna, Vienna 1090, Austria. vineeta.khare@meduniwien.ac.at.
Coleman C; Department of Surgery, University of Kentucky HealthCare, Lexington, KY 40536, USA. ccole2@uky.edu.
Berdel H; Department of Acute Care and Trauma Surgery, University of Kentucky HealthCare, Lexington, KY 40536, USA. Henrik.Berdel@uky.edu.
Gasche C; Department of Internal Medicine III, Medical University of Vienna, Vienna 1090, Austria. christoph.gasche@meduniwien.ac.at.

Geriatrics (Basel) ; 3(4)2018 Oct 19.

Article em En | MEDLINE | ID: mdl-31011108

Palavras-chave

cancer; chemoprevention; inflammation; metformin; p-21 activated kinase; pioglitazone; type 2 diabetes mellitus

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Systematic_reviews Idioma: En Revista: Geriatrics (Basel) Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google